Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Monsanto's (MON) XtendiMax Herbicide Gets EPA Approval

Published 11/10/2016, 05:14 AM
Updated 07/09/2023, 06:31 AM

Monsanto Company (NYSE:MON) recently declared that the U.S. Environmental Protection Agency (‘EPA’) has given a green signal for the usage of its XtendiMax herbicide. It is a less volatile dicamba herbicide and includes the unique VaporGrip technology. The company stated that the herbicide can be used with its Bollgard II XtendFlex cotton and with Roundup Ready 2 Xtend soybeans. In-crop usage of XtendiMax would help farmers to use dicamba in Roundup Ready Xtend Crop System (pending for state sanctions) from 2017.

Monsanto believes that farmers have been looking forward to experience the benefits of the Roundup Ready Xtend Crop System, counting in-crop practice of both glyphosate and dicamba. The farmers would be able to control weeds more consistently and flexibility, with Monsanto’s Roundup Ready Xtend Crop System.

Hence, it would be supporting in maximizing their crop yields. Monsanto estimates that the acreage of Bollgard II XtendFlex cotton and million Roundup Ready 2 Xtend soybean would be more than 3 and 15 million respectively, in 2017.

Monsanto believes that its XtendiMax dicamba herbicide would be widely accepted by the growers as it would be an economical as well as effective weed-control tool.

Existing Scenario

Monsanto accepted Bayer (DE:BAYGN) AG’s (OTC:BAYRY) buyout offer worth $66 billion, inclusive of debt in Sep 2016. The company perceives that the grouping of Bayer would unlock the next tranche of opportunities and growth for its business. The deal is currently subjected to regulatory approvals but the companies expect to accomplish it by the fall of fiscal 2017.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

However, at present, Monsanto carries a Zacks Rank #5 (Strong Sell) due to some major headwinds. External factors such as stiff industry rivalry, a stronger U.S. dollar, weak agricultural product prices and a low cyclical phase in the agricultural industry are currently hurting the company’s revenues and profitability.

Monsanto’s stock price was $98.94 per share as of Nov 9, 2016.

Better-Ranked Stocks that Warrant a Look

Some better-ranked stocks within the industry that warrant a look include:

Coeur Mining, Inc. (NYSE:CDE) currently carries a Zacks Rank #1 (Strong Buy) and has an average positive earnings surprise of 277.67% over the four trailing quarters. You can see the complete list of today’s Zacks #1 Rank stocks here.

Celanese Corp. (NYSE:CE) currently carries a Zacks Rank #2 (Buy) and has an average positive earnings surprise of 7.08% over the last four quarters.

E. I. du Pont de Nemours and Company (NYSE:DD) carries a Zacks Rank #2 and has an average positive earnings surprise of 25.5% over the trailing four quarters.

The Best Place to Start Your Stock Search

Today, you are invited to download the full list of 220 Zacks Rank #1 "Strong Buy" stocks – absolutely free of charge. Since 1988, Zacks Rank #1 stocks have nearly tripled the market, with average gains of +26% per year. Plus, you can access the list of portfolio-killing Zacks Rank #5 "Strong Sells" and other private research. See these stocks free >>



3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
BAYER A G -ADR (BAYRY): Free Stock Analysis Report

DU PONT (EI) DE (DD): Free Stock Analysis Report

CELANESE CP-A (CE): Free Stock Analysis Report

COEUR MINING (CDE): Free Stock Analysis Report

MONSANTO CO-NEW (MON): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.